1 Pick Per Mo for 50% Return Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : 1 Pick Per Mo for 50% Return

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: stockvalinvestor who wrote (1490)	11/20/1997 10:45:00 AM
From: MarcG	Read Replies (1) of 1770

Ken, Thanks, I will. I had held a position in another Red Chip presenter, BIPL, but have traded out profitably based on latest 10Q facts. Another biotech I follow and own, HEB, came out with news this morning. Biovest Research is recommending HEB as a strong buy for risk accounts based on 20 year development of Ampligen, HEB's lead product, and its technology platform. Ampligen, at a threshold in time now, because of where it is in terms of trials and approval for treatment of CFS. FDA has approved the drug for cost recovery program, and Canada has had it available already for CFS and AIDS. Combination with AZT is being tested and may be positive. See: biz.yahoo.com Article by Neenyah Ostron- "Stone-Cold Decade..." posted recently on HEB thread is most informative. Good luck.mg

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next